Immunoproteomic analysis of antibody response to cell wall-associated proteins of Candida tropicalis

Journal of Applied Microbiology

Volumn 117, Issue 3, 2014, Pages 854-865

  Lee, P Y ^a   Gam, L H ^b   Yong, V C ^c   Rosli, R ^a   Ng, K P ^d   Chong, P P ^a,e  

^a UPM   (Malaysia)

^b SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^c TAYLOR S UNIVERSITY   (Malaysia)

^d UNIVERSITY OF MALAYA   (Malaysia)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antigen; Biomarker; Candida tropicalis; Cell wall proteins; Immunoproteomics

Indexed keywords

ANTIGENS; CANDIDA; ESCHERICHIA COLI; RECOMBINANT PROTEINS; YEAST;

ANTIBODIES RESPONSE; ANTIGENICS; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA SPECIES; CANDIDA TROPICALIS; CELL WALL PROTEINS; CELL WALLS; IMMUNOPROTEOMICS; TROPICALIS;

BIOMARKERS;

ANTIBODY; ANTIGEN; CELL MEMBRANE PROTEIN; FUNGAL PROTEIN; IDH2P PROTEIN; KGD2P PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; FUNGUS ANTIBODY; MEMBRANE PROTEIN;

ANTIBODY; BIOASSAY; BIOMARKER; CELL ORGANELLE; GENE EXPRESSION; IMMUNE SYSTEM; PHYSIOLOGICAL RESPONSE; PROTEIN; PROTEOMICS; YEAST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ARTICLE; CANDIDA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; ESCHERICHIA COLI; FUNGAL CELL WALL; FUNGAL STRAIN; HOST; HOST PATHOGEN INTERACTION; IMMUNE SYSTEM; IMMUNOASSAY; IMMUNOPROTEOMICS; INVASIVE CANDIDIASIS; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; SERUM; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CANDIDIASIS; CELL WALL; CHEMISTRY; GENETICS; IMMUNOLOGY;

CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; ESCHERICHIA COLI; MUS;

ANIMALS; ANTIBODIES, FUNGAL; CANDIDA TROPICALIS; CANDIDIASIS; CELL WALL; FUNGAL PROTEINS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; PROTEOMICS; RECOMBINANT PROTEINS;

EID: 85027939942     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/jam.12562     Document Type: Article

References (41)

1. Barchiesi, F., Calabrese, D., Sanglard, D., Di Francesco, L.F., Caselli, F., Giannini, D., Giacometti, A., Gavaudan, S. et al. (2000) Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Chemother 44, 1578-1584.
2. Barea, P.L., Calvo, E., Rodriguez, J.A., Rementeria, A., Calcedo, R., Sevilla, M.J., Pontón, J. and Hernando, F.L. (1999) Characterization of Candida albicans antigenic determinants by two-dimensional polyacrylamide gel electrophoresis and enhanced chemiluminescence. FEMS Immunol Med Microbiol 23, 343-354.
3. Cabezón, V., Llama-Palacios, A., Nombela, C., Monteoliva, L. and Gil, C. (2009) Analysis of Candida albicans plasma membrane proteome. Proteomics 9, 4770-4786.
4. Castillo, L., Calvo, E., Martínez, A.I., Ruiz-Herrera, J., Valentín, E., Lopez, J.A. and Sentandreu, R. (2008) A study of the Candida albicans cell wall proteome. Proteomics 8, 3871-3881.
5. Chaffin, W.L. (2008) Candida albicans cell wall proteins. Microbiol Mol Biol Rev 72, 495-544.
6. Clancy, C., Cheng, S. and Nguyen, M. (2009) Animal Models of Candidiasis. In Candida albicans eds Cihlar, R. and Calderone, R., pp. 65-76. Totowa, New Jersey, USA: Humana Press.
7. Concia, E., Azzini, A.M. and Conti, M. (2009) Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients. Drugs 69, 5-14.
8. Crowe, J.D., Sievwright, I.K., Auld, G.C., Moore, N.R., Gow, N.A.R. and Booth, N.A. (2003) Candida albicans binds human plasminogen: identification of eight plasminogen-binding proteins. Mol Microbiol 47, 1637-1651.
9. Fernández-Arenas, E., Molero, G., Nombela, C., Diez-Orejas, R. and Gil, C. (2004) Contribution of the antibodies response induced by a low virulent Candida albicans strain in protection against systemic candidiasis. Proteomics 4, 1204-1215.
10. Gam, L.H., Leow, C.H., Man, C.N., Gooi, B.H. and Singh, M. (2006) Analysis of differentially expressed proteins in cancerous and normal colonic tissues. World J Gastroenterol 12, 4973-4980.
11. Gozalbo, D., Gil-Navarro, I., Azorín, I., Renau-Piqueras, J., Martínez, J.P. and Gil, M.L. (1998) The cell wall-associated glyceraldehyde-3-phosphate dehydrogenase of Candida albicans is also a fibronectin and laminin binding protein. Infect Immun 66, 2052-2059.
12. Guery, B.P., Arendrup, M.C., Auzinger, G., Azoulay, E., Sá, M.B., Johnson, E.M., Müller, E., Putensen, C. et al. (2009) Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part II. Treatment. Intensive Care Med 35, 206-214.
13. Hamid, S.U., Tan, S., Ahmad Ridzuan, S.N., Che Seman, M.S., Ramli, R. and Khaithir, T.M.N. (2012) Antifungal susceptibility patterns among Candida species isolated from blood at Universiti Kebangsaan Malaysia Medical Centre. Sains Malaysiana 41, 961-967.
14. Hernáez, M.L., Ximénez-Embún, P., Martínez-Gomariz, M., Gutiérrez-Blázquez, M.D., Nombela, C. and Gil, C. (2010) Identification of Candida albicans exposed surface proteins in vivo by a rapid proteomic approach. J Proteomics 73, 1404-1409.
15. Hoehamer, C.F., Cummings, E.D., Hilliard, G.M. and Rogers, P.D. (2010) Changes in the proteome of Candida albicans in response to azole, polyene, and echinocandin antifungal agents. Antimicrob Agents Chemother 54, 1655-1664.
16. Jong, A.Y., Chen, S.H.M., Stins, M.F., Kim, K.S., Tuan, T.L. and Huang, S.H. (2003) Binding of Candida albicans enolase to plasmin(ogen) results in enhanced invasion of human brain microvascular endothelial cells. J Med Microbiol 52, 615-622.
17. Ko, H.C., Hsiao, T.Y., Chen, C.T. and Yang, Y.L. (2013) Candida albicans ENO1 null mutants exhibit altered drug susceptibility, hyphal formation, and virulence. J Microbiol 51, 345-351.
18. Krcmery, V. and Barnes, A.J. (2002) Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 50, 243-260.
19. LaFleur, M.D., Kumamoto, C.A. and Lewis, K. (2006) Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother 50, 3839-3846.
20. Laín, A., Moragues, M.D., Ruiz, J.C.G., Mendoza, J., Camacho, A., del Palacio, A. and Pontón, J. (2007) Evaluation of a novel enzyme-linked immunosorbent assay to detect immunoglobulin G antibody to enolase for serodiagnosis of invasive candidiasis. Clin Vaccine Immunol 14, 318-319.
21. Lee, P.Y., Gam, L.H., Yong, V.C., Rosli, R., Ng, K.P. and Chong, P.P. (2013) Identification of immunogenic proteins of Candida parapsilosis by serological proteome analysis. J Appl Microbiol 116, 999-1009.
22. Li, W.Q., Hu, X.C., Zhang, X., Ge, Y., Zhao, S., Hu, Y. and Ashman, R.B. (2011) Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice. Vaccine 29, 5526-5533.
23. Liu, T.T., Lee, R.E.B., Barker, K.S., Lee, R.E., Wei, L., Homayouni, R. and Rogers, P.D. (2005) Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Chemother 49, 2226-2236.
24. Nucci, M. and Colombo, A.L. (2007) Candidemia due to Candida tropicalis: clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals. Diagn Microbiol Infect Dis 58, 77-82.
25. Okawa, Y., Miyauchi, M. and Kobayashi, H. (2008) Comparison of pathogenicity of various Candida tropicalis strains. Biol Pharm Bull 31, 1507-1510.
26. Ortega, M., Marco, F., Soriano, A., Almela, M., Martínez, J.A., López, J., Pitart, C. and Mensa, J. (2011) Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008. J Hosp Infect 77, 157-161.
27. Pemán, J. and Zaragoza, R. (2010) Current diagnostic approaches to invasive candidiasis in critical care settings. Mycoses 53, 424-433.
28. Pereira, G.H., Müller, P.R., Szeszs, M.W., Levin, A.S. and Melhem, M.S. (2010) Five-year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-C. albicans Candida species. Med Mycol 48, 839-842.
29. Pitarch, A., Sánchez, M., Nombela, C. and Gil, C. (2002) Sequential fractionation and two-dimensional gel analysis unravels the complexity of the dimorphic fungus Candida albicans cell wall proteome. Mol Cell Proteomics 1, 967-982.
30. Pitarch, A., Abian, J., Carrascal, M., Sánchez, M., Nombela, C. and Gil, C. (2004) Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies. Proteomics 4, 3084-3106.
31. Pitarch, A., Jiménez, A., Nombela, C. and Gil, C. (2006) Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by proteomic and bioinformatic analyses. Mol Cell Proteomics 5, 79-96.
32. Pitarch, A., Nombela, C. and Gil, C. (2011) Prediction of the clinical outcome in invasive candidiasis patients based on molecular fingerprints of five anti-Candida antibodies in serum. Mol Cell Proteomics 10, M110.004010.
33. Rodloff, A.C., Koch, D. and Schaumann, R. (2011) Epidemiology and antifungal resistance in invasive candidiasis. Eur J Med Res 16, 187-195.
34. Sambrook, J. and Russell, D.W. (2001) Molecular Cloning: A Laboratory Manual, 3rd edn. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory.
35. Seneviratne, C.J., Wang, Y., Jin, L., Abiko, Y. and Samaranayake, L.P. (2008) Candida albicans biofilm formation is associated with increased anti-oxidative capacities. Proteomics 8, 2936-2947.
36. Thomas, D.P., Viudes, A., Monteagudo, C., Lazzell, A.L., Saville, S.P. and López-Ribot, J.L. (2006) A proteomic-based approach for the identification of Candida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis. Proteomics 6, 6033-6041.
37. Walsh, T.J., Hathorn, J.W., Sobel, J.D., Merz, W.G., Sanchez, V., Maret, S.M., Buckley, H.R., Pfaller, M.A. et al. (1991) Detection of circulating Candida enolase by immunoassay in patients with cancer and invasive candidiasis. N Engl J Med 324, 1026-1031.
38. Wilson, D., Thewes, S., Zakikhany, K., Fradin, C., Albrecht, A., Almeida, R., Brunke, S., Grosse, K. et al. (2009) Identifying infection-associated genes of Candida albicans in the postgenomic era. FEMS Yeast Res 9, 688-700.
39. Wisplinghoff, H., Bischoff, T., Tallent, S.M., Seifert, H., Wenzel, R.P. and Edmond, M.B. (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39, 309-317.
40. Xin, H., Dziadek, S., Bundle, D.R. and Cutler, J.E. (2008) Synthetic glycopeptide vaccines combining β-mannan and peptide epitopes induce protection against candidiasis. Proc Natl Acad Sci U S A 105, 13526-13531.
41. Yang, Y.L., Chen, H.T., Lin, C.C., Chu, W.L., Lo, H.J. and Hospitals, T. (2013) Species distribution and drug susceptibilities of Candida isolates in TSARY 2010. Diagn Microbiol Infect Dis 76, 182-186.